UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000009440 |
|---|---|
| Receipt number | R000011076 |
| Scientific Title | Phase II Study of Weekly Amrubicin in Patients with Refractory or Relapsed Small Cell Lung Cancer (CJLSG1103) |
| Date of disclosure of the study information | 2012/12/03 |
| Last modified on | 2019/09/20 10:02:53 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/11/30 01:45:14 | ||
| 2 | Update | 2013/11/30 14:51:05 | TEL Organization TEL |
|
| 3 | Update | 2015/01/05 16:52:04 | Last follow-up date |
|
| 4 | Update | 2015/06/14 08:24:14 | Recruitment status |
|
| 5 | Update | 2015/11/30 09:19:21 | Recruitment status |
|
| 6 | Update | 2016/05/30 10:08:31 | Name of primary person or sponsor Organization |
|
| 7 | Update | 2016/12/03 12:51:54 | Key inclusion criteria |
|
| 8 | Update | 2017/12/05 13:28:49 | Email |
|
| 9 | Update | 2018/12/05 10:08:33 | Recruitment status Publication of results Results Results |
|
| 10 | Update | 2019/03/22 15:10:42 | Date of IRB |
|
| 11 | Update | 2019/09/20 10:02:53 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
